Deutsche Bank reiterates its Hold rating and $22 target price on Omega Healthcare OHI following initial thoughts on 4Q11 results.
Deutsche Bank says, "Overall, OHI's 4Q results and 2012 outlook were solid, driven by higherthan-expected investment activity while core metrics were stable q/q. However, given the shares' significant outperformance YTD (+12.8% vs +4.8% HC sector avg), we think much of the good news is already priced in. Netnet, a solid Q which includes a 2.5% dividend raise in mid-Jan."
OHI closed at $21.39 a share on Monday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in